Patents by Inventor David Morgens

David Morgens has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of a DHODH inhibitor in combination with an inhibitor of pyrimidine salvage
    Patent number: 10736911
    Abstract: Compounds and methods are provided for the treatment of pathogenic virus infections or cancer. The formulations combine an inhibitor of de novo pyrimidine synthesis, and an inhibitor of a pyrimidine salvage pathway enzyme.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: August 11, 2020
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Richard Deans, Ayse Okesli, David Morgens, Chaitan Khosla, Michael C. Bassik
  • USE OF A DHODH INHIBITOR IN COMBINATION WITH AN INHIBITOR OF PYRIMIDINE SALVAGE
    Publication number: 20190209598
    Abstract: Compounds and methods are provided for the treatment of pathogenic virus infections or cancer. The formulations combine an inhibitor of de novo pyrimidine synthesis, and an inhibitor of a pyrimidine salvage pathway enzyme.
    Type: Application
    Filed: December 22, 2016
    Publication date: July 11, 2019
    Inventors: Richard Deans, Ayse Okesli, David Morgens, Chaitan Khosla, Michael C. Bassik